Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-03 Sale |
2024-06-05 7:23 pm |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer |
822,721 | $54.75 | $45,043,975 | 3,515,007 (Indirect Direct) |
View |
| 2023-11-13 Purchase |
2023-11-15 4:48 pm |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
849,854 | $5.87 | $4,988,643 | 5,329,346 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-16 6:11 pm |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
629,411 | $17 | $10,699,987 | 4,652,427 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-02 Option Award |
2024-01-03 4:52 pm |
N/A 2034-01-01 |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
157,000 | $0 | 157,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:34 pm |
N/A 2033-01-02 |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:27 pm |
N/A 2032-01-02 |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
116,750 | $0 | 116,750 (Direct) |
View |
| 2021-06-15 Conversion |
2021-06-16 6:11 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
6,855,609 | $0 | 4,652,427 (Indirect) |
View |
Ownership |
2021-06-10 7:18 pm |
N/A N/A |
Janux Therapeutics Inc. | JANX | Reardon Tighe Acting Chief Financial Officer 10% Owner |
0 | $0 | 4,215,166 (Direct) |
View |